These compounds may interact with:
Opioid growth factor receptor-like protein 1
Potentially involved in: carcinoma; adrenocortical carcinoma; atypical teratoid / rhabdoid tumor; breast cancer; breast carcinoma; cystic fibrosis; ependymoma; glioblastoma; group 3 medulloblastoma; interstitial cystitis; invasive ductal carcinoma; lung cancer; lung carcinoma; malignant mesothelioma; medulloblastoma, large-cell; non primary sjogren syndrome sicca; osteosarcoma; ovarian cancer; pediatric high grade glioma; primitive neuroectodermal tumor
Disease data sourced from Pharos.